Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses.

[1]  J. Millar,et al.  [Complications of smallpox vaccination]. , 2010, [Hokenfu zasshi] The Japanese journal for public health nurse.

[2]  H. Salomón,et al.  Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B. , 2009, Virus research.

[3]  D. Montefiori,et al.  Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination , 2009, Mucosal Immunology.

[4]  S. Akira,et al.  Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome , 2009, PLoS pathogens.

[5]  A. Adamson,et al.  The Current STATus of lymphocyte signaling: new roles for old players. , 2009, Current opinion in immunology.

[6]  G. Ciliberto,et al.  The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells , 2009, The Journal of experimental medicine.

[7]  Shohei Koyama,et al.  Innate immune response to viral infection. , 2008, Cytokine.

[8]  S. Akira,et al.  Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. , 2008, The Journal of clinical investigation.

[9]  Xiaopei Huang,et al.  Direct Action of Type I IFN on NK Cells Is Required for Their Activation in Response to Vaccinia Viral Infection In Vivo1 , 2008, The Journal of Immunology.

[10]  S. Ishihara,et al.  CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells , 2007, Nature Immunology.

[11]  Osamu Takeuchi,et al.  Genetic analysis of resistance to viral infection , 2007, Nature Reviews Immunology.

[12]  V. Kuchroo,et al.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.

[13]  Xiaopei Huang,et al.  Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. , 2007, Blood.

[14]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[15]  G. Karupiah,et al.  Obligatory Requirement for Antibody in Recovery from a Primary Poxvirus Infection , 2006, Journal of Virology.

[16]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[18]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[19]  Andrew Pekosz,et al.  Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. , 2005, Virology.

[20]  Peter O. Krutzik,et al.  Characterization of the Murine Immunological Signaling Network with Phosphospecific Flow Cytometry1 , 2005, The Journal of Immunology.

[21]  G. Karupiah,et al.  Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Peter O. Krutzik,et al.  Intracellular phospho‐protein staining techniques for flow cytometry: Monitoring single cell signaling events , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[23]  S. Bhattacharya,et al.  Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.

[24]  R. Welsh,et al.  Innate Immunity to Viruses: Control of Vaccinia Virus Infection by γδ T Cells1 , 2001, The Journal of Immunology.

[25]  Stephen Shaw,et al.  Lymph-Borne Chemokines and Other Low Molecular Weight Molecules Reach High Endothelial Venules via Specialized Conduits While a Functional Barrier Limits Access to the Lymphocyte Microenvironments in Lymph Node Cortex , 2000, The Journal of experimental medicine.

[26]  R. Wittek,et al.  Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. , 1999, Virology.

[27]  M. Wiles,et al.  Interleukin 6 Influences Germinal Center Development and Antibody Production via a Contribution of C3 Complement Component , 1998, The Journal of experimental medicine.

[28]  S. Akira,et al.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. , 1998, Journal of immunology.

[29]  G. Karupiah,et al.  Cytokines and immunity to viral infections , 1997, Immunological reviews.

[30]  J. Banchereau,et al.  Inability to produce IL-6 is a functional feature of human germinal center B lymphocytes. , 1996, Journal of immunology.

[31]  K. Winestock,et al.  IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.

[32]  A. Alcamí,et al.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.

[33]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[34]  A. Husband,et al.  The role of interleukin-6 in mucosal IgA antibody responses in vivo. , 1994, Science.

[35]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[36]  P. Morrissey,et al.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Miyazaki,et al.  IgG1 plasmacytosis in interleukin 6 transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Buller,et al.  Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality , 1985, Journal of virology.

[39]  T. Hirano,et al.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. Fenner.  Mousepox (infectious ectromelia): past, present, and future. , 1981, Laboratory animal science.

[41]  J D Millar,et al.  Complications of smallpox vaccination, 1968. , 1969, The New England journal of medicine.

[42]  F. Fenner,et al.  Mouse-pox; infectious ectromelia of mice; a review. , 1949, Journal of immunology.

[43]  G. McFadden.  Poxvirus tropism , 2005, Nature Reviews Microbiology.

[44]  R. Buller,et al.  Poxvirus pathogenesis. , 1991, Microbiological reviews.

[45]  V. M. Tarabrina.  [On complications in smallpox vaccination]. , 1961, Sovetskaia meditsina.